Imiquimod (Compound)

Synonyms:IMIQUIMOD, 99011-02-6, Aldara, Zyclara, 1-isobutyl-1H-imidazo[4,5-c]quinolin-4-amine, 1-(2-methylpropyl)-1H-imidazo[4,5-c]quinolin-4-amine, Beselna, 4-Amino-1-isobutyl-1H-imidazo[4,5-c]quinoline, R 837, 1-(2-methylpropyl)imidazo[4,5-c]quinolin-4-amine, 4-Amino-1-isobutyl-1H-imidazo(4,5-c)quinoline, R-837, 9050-31-1, S-26308, C14H16N4, UNII-P1QW714R7M, MFCD00866946, CHEMBL1282, 1-isobutylimidazo[4,5-c]quinolin-4-amine, P1QW714R7M, 1H-Imidazo[4,5-c]quinolin-4-amine, 1-(2-methylpropyl)-, CHEBI:36704, S26308, 1H-Imidazo(4,5-c)quinolin-4-amine, 1-(2-methylpropyl)-, NCGC00070736-02, Zartra, Imiquimod acetate, DSSTox_CID_21047, DSSTox_RID_79617, DSSTox_GSID_41047, Aldara (TN), CAS-99011-02-6, S 26308, SR-01000611320, Imiquimodum, Imiquimod [USAN:INN:BAN], Vyloma, MTD-39, 1-(2-Methylpropyl)-1H-imidazole[4,5-c]quinoline-4-amine, HSDB 8129, TMX 101, TMX-101, Aldara|||Beselna, Imiquimod,(S), Imiquimod- Bio-X, 6T0, Imiquimod - Aldara, Zyclara (TN), DZ-2636, (non-labelled)Imiquimod-d9, Imiquimod (JAN/USP/INN), SCHEMBL26136, MLS000083577, BIDD:GT0859, GTPL5003, DTXSID7041047, AOB6939, HMS2090M14, HMS2232G07, HMS3373B13, HMS3715N19, HMS3747A13, Pharmakon1600-01502351, BCP05151, HY-B0180, Tox21_110985, AC-529, BBL010772, BDBM50240849, NSC369100, NSC759651, NSC811538, s1211, STK583860, ZINC19632912, Imiquimod - CAS 99011-02-6, Imiquimod, >=98% (HPLC), solid, AKOS005507352, Tox21_110985_1, 1H-Imidazo[4, 1-(2-methylpropyl)-, CCG-208015, CS-2058, DB00724, KS-5218, MCULE-9421195760, NSC 369100, NSC 741062, NSC 759651, NSC-369100, NSC-759651, NSC-811538, YH44175, (Hydroxypropyl)methyl cellulose phthalate, Imiquimod 100 microg/mL in Acetonitrile, NCGC00070736-03, NCGC00070736-04, BI164576, SMR000048307, SY017571, FT-0602727

Pubchem:PUBCHEM:57469

Id:57469

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Imiquimod's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Imiquimod.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Imiquimod.

Results found

Linked to

	Label	Description
	BRD-K26657438-001-01-2 Substance (Entity type)	A Substance
	imiquimod (517a5498-639b-4d38-b7e4-4b2bf07aff41) Collection (Entity type)	Metadatata for imiquimod
	DCSTRUCT ID 01429 Collection (Entity type)	DrugPage Collection: (DrugCentralID:01429; PubChem_CID:57469, FILE=drugcentral_drug_01429.json)
	imiquimod indication Warts Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	lacitol in similarity relationship with imiquimod Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	imiquimod negatively regulates SORBS3 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	imiquimod in similarity relationship with desoxypeganine Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	imiquimod positively regulates CXCL1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	imiquimod in similarity relationship with Marbofloxacin Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	acebutolol in similarity relationship with imiquimod Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS